Literature DB >> 25595959

National data on stroke outcomes in Thailand.

Kannikar Kongbunkiat1, Narongrit Kasemsap2, Kaewjai Thepsuthammarat3, Somsak Tiamkao1, Kittisak Sawanyawisuth4.   

Abstract

Stroke is a major public health problem worldwide. There are limited data on national stroke prevalence and outcomes after the beginning of the thrombolytic therapy era in Thailand. This study aimed to investigate the prevalence and factors associated with mortality in stroke patients in Thailand using the national reimbursement databases. Clinical data retrieved included individuals under the universal coverage, social security, and civil servant benefit systems between 1 October 2009 and 30 September 2010. The stroke diagnosis code was based on the International Classification of Diseases 10th revision system including G45 (transient cerebral ischemic attacks and related syndromes), I61 (intracerebral hemorrhage), and I63 (cerebral infarction). The prevalence and stroke outcomes were calculated from these coded data. Factors associated with death were evaluated by multivariable logistic regression analysis. We found that the most frequent stroke subtype was cerebral infarction with a prevalence of 122 patients per 100,000 of population, an average length of hospital stay of 6.8 days, an average hospital charge of 20,740 baht (∼$USD 691), a mortality rate of 7%, and thrombolytic prescriptions of 1%. The significant factors associated with stroke mortality were septicemia, pulmonary embolism, pneumonia, myocardial infarction, status epilepticus, and heart failure. In conclusion, the prevalence and outcomes of stroke in Thailand were comparable with other countries. The era of thrombolytic therapy has just begun in Thailand.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ICD-10; National data; Outcomes; Predictors; Stroke; Thailand

Mesh:

Substances:

Year:  2015        PMID: 25595959     DOI: 10.1016/j.jocn.2014.08.031

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  7 in total

Review 1.  Association between seizures after ischemic stroke and stroke outcome: A systematic review and meta-analysis.

Authors:  Tao Xu; Shu Ou; Xi Liu; Xinyuan Yu; Jinxian Yuan; Hao Huang; Yangmei Chen
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

2.  Knowledge of Stroke Risk Factors and Warning Signs in Patients with Recurrent Stroke or Recurrent Transient Ischaemic Attack in Thailand.

Authors:  Jittima Saengsuwan; Pathitta Suangpho; Somsak Tiamkao
Journal:  Neurol Res Int       Date:  2017-10-09

3.  Factors Associated with Unfavorable Functional Outcomes After Intravenous Thrombolysis in Patients with Acute Ischemic Stroke.

Authors:  Nat Satumanatpan; Warinyupa Tonpho; Nutchanon Thiraratananukulchai; Pheerawat Chaichanamongkol; Pittawat Lekcharoen; Kitti Thiankhaw
Journal:  Int J Gen Med       Date:  2022-03-25

4.  Factors associated with favorable outcomes in acute severe stroke patients: A real-world, national database study.

Authors:  Narongrit Kasemsap; Nisa Vorasoot; Kannikar Kongbunkiat; Somsak Tiamkao; Watchara Boonsawat; Kittisak Sawanyawisuth
Journal:  Biomed Rep       Date:  2022-07-22

5.  Prehospital time of suspected stroke patients treated by emergency medical service: a nationwide study in Thailand.

Authors:  Phantakan Tansuwannarat; Pongsakorn Atiksawedparit; Arrug Wibulpolprasert; Natdanai Mankasetkit
Journal:  Int J Emerg Med       Date:  2021-07-19

6.  Impact of intravenous thrombolysis on length of hospital stay in cases of acute ischemic stroke.

Authors:  Narongrit Kasemsap; Nisa Vorasoot; Kannikar Kongbunkiat; Udomlack Peansukwech; Somsak Tiamkao; Kittisak Sawanyawisuth
Journal:  Neuropsychiatr Dis Treat       Date:  2018-01-09       Impact factor: 2.570

7.  Variation of Autonomic Nervous System Function by Age and Gender in Thai Ischemic Stroke Patients.

Authors:  Warawoot Chuangchai; Wiraporn Pothisiri; Phumdecha Chanbenjapipu
Journal:  Brain Sci       Date:  2021-03-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.